{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:56:05Z","timestamp":1775274965905,"version":"3.50.1"},"reference-count":118,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T00:00:00Z","timestamp":1700956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"publisher","award":["JP22H03520"],"award-info":[{"award-number":["JP22H03520"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Calpain is defined as a member of the superfamily of cysteine proteases possessing the CysPC motif within the gene. Calpain-1 and -2, which are categorized as conventional isozymes, execute limited proteolysis in a calcium-dependent fashion. Accordingly, the calpain system participates in physiological and pathological phenomena, including cell migration, apoptosis, and synaptic plasticity. Recent investigations have unveiled the contributions of both conventional and unconventional calpains to the pathogenesis of cardiometabolic disorders. In the context of atherosclerosis, overactivation of conventional calpain attenuates the barrier function of vascular endothelial cells and decreases the immunosuppressive effects attributed to lymphatic endothelial cells. In addition, calpain-6 induces aberrant mRNA splicing in macrophages, conferring atheroprone properties. In terms of diabetes, polymorphisms of the calpain-10 gene can modify insulin secretion and glucose disposal. Moreover, conventional calpain reportedly participates in amino acid production from vascular endothelial cells to induce alteration of amino acid composition in the liver microenvironment, thereby facilitating steatohepatitis. Such multifaceted functionality of calpain underscores its potential as a promising candidate for pharmaceutical targets for the treatment of cardiometabolic diseases. Consequently, the present review highlights the pivotal role of calpains in the complications of cardiometabolic diseases and embarks upon a characterization of calpains as molecular targets.<\/jats:p>","DOI":"10.3390\/ijms242316782","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T03:32:03Z","timestamp":1701055923000},"page":"16782","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Calpain and Cardiometabolic Diseases"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3354-0292","authenticated-orcid":false,"given":"Takuro","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Showa University School of Medicine, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41591-020-0786-7","article-title":"Improving prevention strategies for cardiometabolic disease","volume":"26","author":"Sattar","year":"2020","journal-title":"Nat. Med."},{"key":"ref_2","first-page":"89","article-title":"Polygenic risk scores for the prediction of cardiometabolic disease","volume":"44","author":"Elliott","year":"2022","journal-title":"Eur. Hear J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/14740338.2022.2044472","article-title":"An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: A review of safety profiles","volume":"21","author":"Ogata","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Review of Shared Cardiometabolic Risk Factors","volume":"79","author":"Peng","year":"2022","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MOL.0000000000000652","article-title":"Fatty liver, cardiometabolic disease, and mortality","volume":"31","author":"Bedogni","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tcm.2019.01.001","article-title":"Effect of statins on atherosclerotic plaque","volume":"29","author":"Almeida","year":"2019","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic Effects of Statins on the Cardiovascular System","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S2468-1253(22)00338-7","article-title":"Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease","volume":"8","author":"Targher","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13679-019-00345-1","article-title":"Nonalcoholic Fatty Liver Disease and Obesity Treatment","volume":"8","author":"Brunner","year":"2019","journal-title":"Curr. Obes. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41581-020-00350-x","article-title":"Organ protection by SGLT2 inhibitors: Role of metabolic energy and water conservation","volume":"17","author":"Marton","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: Established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd.2016.212","article-title":"Calpain research for drug discovery: Challenges and potential","volume":"15","author":"Ono","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00018-017-2528-7","article-title":"Emerging roles of calpain proteolytic systems in macrophage cholesterol handling","volume":"74","author":"Miyazaki","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.2174\/1381612827666210311143053","article-title":"Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer","volume":"27","author":"Miyazaki","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2174\/0929867325666180326165234","article-title":"Impact of Dysfunctional Protein Catabolism on Macrophage Cholesterol Handling","volume":"26","author":"Miyazaki","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fcvm.2017.00079","article-title":"Defective Protein Catabolism in Atherosclerotic Vascular Inflammation","volume":"4","author":"Miyazaki","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41232-020-00114-x","article-title":"Calpain proteolytic systems counteract endothelial cell adaptation to inflammatory en-vironments","volume":"40","author":"Miyazaki","year":"2020","journal-title":"Inflamm. Regen."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00029.2002","article-title":"The calpain system","volume":"83","author":"Goll","year":"2003","journal-title":"Physiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ono, Y., and Sorimachi, H. (2012). Calpains: An elaborate proteolytic system. Biochim. Biophys. Acta, 1824.","DOI":"10.1016\/j.bbapap.2011.08.005"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.RV17008","article-title":"Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders","volume":"25","author":"Miyazaki","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1074\/mcp.M115.053413","article-title":"Predictions of Cleavability of Calpain Proteolysis by Quantitative Structure-Activity Relationship Analysis Using Newly Determined Cleavage Sites and Catalytic Efficiencies of an Oligopeptide Array","volume":"15","author":"Koyama","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.116.305363","article-title":"Calpastatin Counteracts Pathological Angiogenesis by Inhibiting Suppressor of Cytokine Signaling 3 Degradation in Vascular Endothelial Cells","volume":"116","author":"Miyazaki","year":"2015","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.yjmcc.2019.03.006","article-title":"Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury","volume":"129","author":"Barefield","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0014-5793(87)80531-8","article-title":"All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II","volume":"223","author":"Maki","year":"1987","journal-title":"FEBS Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/oxfordjournals.jbchem.a134134","article-title":"Purification and Some Properties of Human Erythrocyte Calpastatin1","volume":"92","author":"Takano","year":"1982","journal-title":"J. Biochem."},{"key":"ref_27","first-page":"1125.e9","article-title":"Calpastatin modulates APP processing in the brains of \u03b2-amyloid depositing but not wild-type mice","volume":"33","author":"Berger","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1471-4159.2011.07222.x","article-title":"Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25","volume":"117","author":"Sato","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1096\/fj.11-187740","article-title":"Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology","volume":"26","author":"Higuchi","year":"2011","journal-title":"FASEB J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuropharm.2018.01.022","article-title":"Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease","volume":"133","author":"Weber","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ling, C., Groop, L., Guerra, S.D., and Lupi, R. (2009). Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006558"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/79876","article-title":"Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus","volume":"26","author":"Horikawa","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3906\/sag-1701-174","article-title":"Investigation of glucocorticoid receptor and calpain-10 gene polymorphisms in Turkish patients with type 2 diabetes mellitus","volume":"47","author":"Bayramci","year":"2017","journal-title":"Turk. J. Med Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3892\/br.2016.833","article-title":"Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes","volume":"6","author":"Karambataki","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tonami, K., Hata, S., Ojima, K., Ono, Y., Kurihara, Y., Amano, T., Sato, T., Kawamura, Y., Kurihara, H., and Sorimachi, H. (2013). Cal-pain-6 deficiency promotes skeletal muscle development and regeneration. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003668"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/geno.1997.4870","article-title":"A new subfamily of vertebrate calpains lacking a calmodulin-like domain: Implications for calpain regulation and evolution","volume":"45","author":"Dear","year":"1997","journal-title":"Genomics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: Recent developments","volume":"185","author":"Lusis","year":"2022","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis is an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_39","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: Mediators and therapeutic opportunities","volume":"16","author":"Yurdagul","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physrev.00012.2005","article-title":"Signaling Mechanisms Regulating Endothelial Permeability","volume":"86","author":"Mehta","year":"2006","journal-title":"Physiol. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0008-6363(99)00125-X","article-title":"Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation","volume":"43","author":"Bobryshev","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/CIRCULATIONAHA.107.746008","article-title":"Rapid Endothelial Turnover in Atherosclerosis-Prone Areas Coincides With Stem Cell Repair in Apolipoprotein E\u2013Deficient Mice","volume":"117","author":"Foteinos","year":"2008","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1074\/jbc.M208772200","article-title":"The role of calpain in the proteolytic cleavage of e-cadherin in prostate and mammary epithelial cells","volume":"278","author":"Day","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1523\/JNEUROSCI.6178-08.2009","article-title":"Calpain-Mediated N-Cadherin Proteolytic Processing in Brain Injury","volume":"29","author":"Jang","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1161\/CIRCULATIONAHA.111.021675","article-title":"m-calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis","volume":"124","author":"Miyazaki","year":"2011","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1091\/mbc.e16-09-0658","article-title":"The VE-cadherin cytoplasmic domain undergoes proteolytic processing during endocytosis","volume":"28","author":"Su","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12980","DOI":"10.1073\/pnas.1902165116","article-title":"Endothelial cell Piezo1 mediates pressure-induced lung vascular hyperpermeability via disruption of adherens junctions","volume":"116","author":"Friedrich","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Guo, X.-W., Zhang, H., Huang, J.-Q., Wang, S.-N., Lu, Y., Cheng, B., Dong, S.-H., Wang, Y.-Y., Li, F.-S., and Li, Y.-W. (2021). PIEZO1 Ion Channel Mediates Ionizing Radiation-Induced Pulmonary Endothelial Cell Ferroptosis via Ca2+\/Calpain\/VE-Cadherin Signaling. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.725274"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Sun, X., Sun, Y., Jiang, P., Qi, G., and Chen, X. (2020). Crosstalk between endothelial cell-specific calpain inhibition and the endotheli-al-mesenchymal transition via the HSP90\/Akt signaling pathway. Biomed. Pharmacother., 124.","DOI":"10.1016\/j.biopha.2020.109822"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41232-016-0012-7","article-title":"Metabolic regulation by secreted phospholipase A2","volume":"36","author":"Sato","year":"2016","journal-title":"Inflamm. Regen."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0891-5849(00)00344-0","article-title":"The oxidative modification hypothesis of atherogenesis: An overview","volume":"28","author":"Chisolm","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2174\/092986707782793899","article-title":"Role of Lysophosphatidylcholine (LPC) in Atherosclerosis","volume":"14","author":"Matsumoto","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yexcr.2015.03.016","article-title":"Lysophospholipid mediators in the vasculature","volume":"333","author":"Mueller","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/ATVBAHA.120.305565","article-title":"Lysolipids in Vascular Development, Biology, and Disease","volume":"41","author":"Engelbrecht","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.039697","article-title":"Targeting filamin A reduces macrophage activity and atherosclerosis","volume":"140","author":"Bandaru","year":"2019","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1139\/cjpp-2016-0652","article-title":"Calpain inhibitor I attenuates atherosclerosis and inflammation in ath-erosclerotic rats through eNOS\/NO\/NF-\u03baB pathway","volume":"96","author":"Yu","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1139\/cjpp-2016-0295","article-title":"Simvastatin inhibited oxLDL-induced proatherogenic effects through the calpain-1-PPAR\u03b3-CD36 pathway","volume":"94","author":"Yang","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000464288","article-title":"Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice","volume":"54","author":"Yin","year":"2017","journal-title":"J. Vasc. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"701229","DOI":"10.3389\/fcvm.2021.701229","article-title":"Hypercholesterolemia and lymphatic defects: The chicken or the egg?","volume":"8","author":"Miyazaki","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cmet.2013.04.002","article-title":"Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL","volume":"17","author":"Lim","year":"2013","journal-title":"Cell Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/eci.12372","article-title":"Lymphatic vessels: An emerging actor in athero-sclerotic plaque development","volume":"45","author":"Kutkut","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI63685","article-title":"Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice","volume":"123","author":"Martel","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"srep45263","DOI":"10.1038\/srep45263","article-title":"Adventitial lymphatic capillary expansion impacts on plaque T cell accumulation in atherosclerosis","volume":"7","author":"Rademakers","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1161\/ATVBAHA.122.317781","article-title":"Hypercholesterolemic Dysregulation of Calpain in Lymphatic Endothelial Cells Interferes With Regulatory T-Cell Stability and Trafficking","volume":"43","author":"Miyazaki","year":"2023","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jbmr.241","article-title":"Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation","volume":"26","author":"Hong","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Andrique, C., Morardet, L., Linares, L.K., Ciss\u00e9, M.Y., Merle, C., Chibon, F., Provot, S., Ha\u00ff, E., Ea, H.-K., and Cohen-Solal, M. (2018). Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence. J. Clin. Investig., 3.","DOI":"10.1172\/jci.insight.121225"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1172\/JCI85880","article-title":"Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicing","volume":"126","author":"Miyazaki","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1242\/jcs.072561","article-title":"Calpain-6, a microtubule-stabilizing protein, regulates Rac1 activity and cell motility through interaction with GEF-H1","volume":"124","author":"Tonami","year":"2011","journal-title":"J. Cell Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1093\/nar\/gkv320","article-title":"CWC22-dependent pre-mRNA splicing and eIF4A3 binding enables global deposition of exon junction complexes","volume":"43","author":"Steckelberg","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Woodward, L.A., Mabin, J.W., Gangras, P., and Singh, G. (2016). The exon junction complex: A lifelong guardian of mRNA fate. Wiley Interdiscip. Rev. RNA, 8.","DOI":"10.1002\/wrna.1411"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.celrep.2012.08.017","article-title":"CWC22 connects pre-mRNA splicing and exon junction complex assembly","volume":"2","author":"Steckelberg","year":"2012","journal-title":"Cell Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: A dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_74","first-page":"386","article-title":"Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles","volume":"22","author":"Kruth","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1074\/jbc.M407167200","article-title":"Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein","volume":"280","author":"Kruth","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.lfs.2003.09.009","article-title":"Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases","volume":"74","author":"Seachrist","year":"2003","journal-title":"Life Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1172\/JCI35548","article-title":"Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions","volume":"119","author":"Buono","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.2174\/1381612811319330005","article-title":"Fluid-Phase Pinocytosis of LDL by Macrophages: A Novel Target to Reduce Macrophage Cholesterol Accumulation in Atherosclerotic Lesions","volume":"19","author":"Kruth","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_79","first-page":"608","article-title":"Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima","volume":"12","author":"Steinbrecher","year":"1992","journal-title":"Arter. Thromb. A J. Vasc. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1172\/JCI10665","article-title":"A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance","volume":"106","author":"Baier","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_81","first-page":"231","article-title":"SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: The atherosclerosis risk in communities study","volume":"51","author":"Garant","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/323315","article-title":"Studies on the correlation between the calpain-10 gene and type 2 diabetes mellitus in the United Kingdom","volume":"69","author":"Evans","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2337\/diabetes.50.9.2161","article-title":"Functional relevance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans","volume":"50","author":"Stumvoll","year":"2001","journal-title":"Diabetes"},{"key":"ref_84","first-page":"1498","article-title":"Lack of Association of type 2 diabetes with CAPN10 and PC-1 Poly-morphisms in Oji-Cree","volume":"24","author":"Hegele","year":"2001","journal-title":"Int. J. Mol. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1210\/jcem.87.2.8210","article-title":"Role of calpain-10 gene variants in familial type 2 diabetes in caucasians","volume":"87","author":"Hegele","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2337\/diabetes.51.5.1622","article-title":"Haplotype Combinations of Calpain 10 Gene Polymorphisms Associate With Increased Risk of Impaired Glucose Tolerance and Type 2 Diabetes in South Indians","volume":"51","author":"Cassell","year":"2002","journal-title":"Diabetes"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2337\/diabetes.51.1.247","article-title":"Variation in the Calpain-10 Gene Affects Blood Glucose Levels in the British Population","volume":"51","author":"Lynn","year":"2002","journal-title":"Diabetes"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj20030681","article-title":"Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes","volume":"376","author":"Paul","year":"2003","journal-title":"Biochem. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ymgme.2007.05.001","article-title":"Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells","volume":"91","author":"Brown","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbrc.2006.11.077","article-title":"Calpain facilitates actin reorganization during glucose-stimulated insulin secretion","volume":"352","author":"Turner","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2337\/diabetes.50.9.2013","article-title":"Calpains Play a Role in Insulin Secretion and Action","volume":"50","author":"Sreenan","year":"2001","journal-title":"Diabetes"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/meta.2003.50091","article-title":"A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin","volume":"52","author":"Zhou","year":"2003","journal-title":"Metabolism"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35204-x","article-title":"Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B","volume":"8","author":"Hatta","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"The Soluble Insulin Receptor Study Group (2007). Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes. Diabetes, 56, 2028\u20132035.","DOI":"10.2337\/db07-0394"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00125-016-4102-5","article-title":"Sequential cleavage of insulin receptor by calpain 2 and \u03b3-secretase impairs insulin signalling","volume":"59","author":"Yuasa","year":"2016","journal-title":"Diabetologia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e002467","DOI":"10.1136\/bmjdrc-2021-002467","article-title":"Insulin receptor cleavage induced by estrogen impairs insulin signaling","volume":"9","author":"Yuasa","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s00125-019-4828-y","article-title":"Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis","volume":"62","author":"Teng","year":"2019","journal-title":"Diabetologia"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jcmm.17642","article-title":"Experimental diabetes exacerbates autophagic flux impairment during myocardial I\/R injury through calpain-mediated cleavage of Atg5\/LAMP2","volume":"27","author":"Guan","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41401-020-00526-y","article-title":"Targeted inhibition of mitochondrial calpain alleviates oxidative stress-induced myocardial injury","volume":"42","author":"Zheng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aav0558","article-title":"Branched-chain amino acids in disease","volume":"363","author":"White","year":"2019","journal-title":"Science"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"101198","DOI":"10.1016\/j.arr.2020.101198","article-title":"Branched chain amino acids, aging and age-related health","volume":"64","author":"Cogger","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: Where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Fiehn, O., Garvey, W.T., Newman, J.W., Lok, K.H., Hoppel, C.L., and Adams, S.H. (2010). Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015234"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1038\/ncomms8940","article-title":"A hepatic amino acid\/mTOR\/S6K-dependent signalling pathway modulates systemic lipid metabolism via neuronal signals","volume":"6","author":"Uno","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"31582","DOI":"10.1074\/jbc.M506736200","article-title":"Autophagy Is Required for Maintenance of Amino Acid Levels and Protein Synthesis under Nitrogen Starvation","volume":"280","author":"Onodera","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molcel.2012.08.003","article-title":"Failure of amino acid homeostasis causes cell death following pro-teasome inhibition","volume":"48","author":"Suraweera","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16003-3","article-title":"A masked initiation region in retinoblastoma protein regulates its proteasomal degradation","volume":"11","author":"Tomita","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Akasu, R., Miyazaki, T., Elhussiny, M.Z., Sugiura, Y., Tomitsuka, Y., Haraguchi, S., Otsu, K., Chowdhury, V.S., and Miyazaki, A. (2022). Calpain-mediated proteolytic production of free amino acids in vascular endothelial cells augments obesity-induced hepatic steatosis. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2022.101953"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/fsn3.2002","article-title":"Knockout of calpain-1 protects against high-fat diet-induced liver dysfunction in mouse through inhibiting oxidative stress and inflammation","volume":"9","author":"Xu","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1096\/fj.201800588RR","article-title":"Endothelial calpain systems orchestrate myofibroblast dif-ferentiation during wound healing","volume":"33","author":"Miyazaki","year":"2019","journal-title":"FASEB J."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Sato, T., Head, K.Z., Li, J., Dolin, C.E., Wilkey, D., Skirtich, N., Smith, K., McCreary, D.D., Liu, S., and Beier, J.I. (2022). Fibrosis resolution in the mouse liver: Role of Mmp12 and potential role of calpain 1\/2. Matrix Biol. Plus, 17.","DOI":"10.1101\/2022.02.15.480540"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5487\/TR.2011.27.1.001","article-title":"Lipid Peroxidation and Its Toxicological Implications","volume":"27","author":"Nam","year":"2011","journal-title":"Toxicol. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jcmgh.2022.06.008","article-title":"Hydroxynonenal Causes Hepatocyte Death by Disrupting Lysosomal Integrity in Nonalcoholic Steatohepatitis","volume":"14","author":"Seike","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Flores-Toro, J., Chun, S.-K., Shin, J.-K., Campbell, J., Lichtenberger, M., Chapman, W., Zendejas, I., Behrns, K., Leeuwenburgh, C., and Kim, J.-S. (2021). Critical Roles of Calpastatin in Ischemia\/Reperfusion Injury in Aged Livers. Cells, 10.","DOI":"10.3390\/cells10081863"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3892\/mmr.2021.12314","article-title":"miR 140 5p alleviates mouse liver ische-mia\/reperfusion injury by targeting CAPN1","volume":"24","author":"Yu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5551\/jat.3939","article-title":"Adipose tissue, inflammation, and atherosclerosis","volume":"17","author":"Santos","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Cuevas, J., Santos, A., and Armendariz-Borunda, J. (2021). Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111629"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"14398","DOI":"10.1038\/s41598-017-14719-9","article-title":"Calpain Inhibition Attenuates Adipose Tissue Inflammation and Fibrosis in Diet-induced Obese Mice","volume":"7","author":"Muniappan","year":"2017","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/23\/16782\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:30:48Z","timestamp":1760131848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/23\/16782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,26]]},"references-count":118,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["ijms242316782"],"URL":"https:\/\/doi.org\/10.3390\/ijms242316782","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,26]]}}}